ANTI-CD19

Clinical trials for ANTI-CD19 explained in plain language.

Never miss a new study

Get alerted when new ANTI-CD19 trials appear

Sign up with your email to follow new studies for ANTI-CD19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New antibody tested for rare bleeding disorder

Disease control Recruiting now

This early-stage study is testing a new antibody drug called budoprutug in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The main goal is to check if the drug is safe and well-tolerated, while also seeing if it helps raise plate…

Matched conditions: ANTI-CD19

Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

ANTI-CD19

Get alerted when new ANTI-CD19 trials appear

New antibody tested for rare bleeding disorder